Plasma Expressor Machine Market Size & Share, by Type (Manual, Automatic); Application (Plasma Separation, Chemical Research, Blood Testing, Pharmaceutical Research); End-user (Hospital, Institutes & Research Centers, Blood Bank) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

Plasma Expressor Machine Market size was valued at USD 113.02 million in 2024 and is likely to cross USD 176.76 million by 2037, registering more than 3.5% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of plasma expressor machine is estimated at USD 116.38 million.

Plasma expressor machine is a device used to separate plasma, RBC, WBC and platelets from the blood. Basically, it is used for easy and efficient blood component separation in any manner. Various diseases, such as, leukopenia or neutropenia require only the white blood cells, while dengue treatment requires platelets separately.  The growth of the market can be attributed to the growing need for any specific component of blood to treat various rare diseases. Blood cancer, such as, leukemia, lymphoma, and myeloma, are the primary disorders which entail the need for plasma expressor machines.

Moreover, the growing prevalence of blood cancer is estimated to boost the plasma expressor machine market growth. As per the data by the World Cancer Research Fund (WCRF), an estimated 18.1 million cancer cases were diagnosed around the world in 2020. Out of these, 18,094,716 new cancer cases were reported in 2020 itself. Among these, leukemia accounted for 474,519 cases, Hodgkin lymphoma accounted for 83,087 cases, and multiple myeloma accounted for 176,404 cases globally.